
Keywords: ترمیم مجدد مکمل گروه 1; AC; adenocarcinoma; EGFR; epidermal growth factor receptor; ERCC1; Excision repair cross-complementation group 1; LCNEC; large cell neuroendocrine carcinoma; NSCLC; non-small cell lung carcinoma; OS; overall survival; SCLC; small cell lung carcinoma; SST;